CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 66 enrolled
Drug / intervention
Lens 1 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06328660
NCT06328660N/ACompleted
CompareCT.gov

Refitting Biofinity Multifocal Contact Lens Wearer With MyDay Multifocal Contact Lenses

CooperVision International Limited (CVIL)·interventional·Posted Mar 25, 2024·Updated Jul 28, 2025

In Brief

A clinical study evaluating Lens 1 and Lens 2 for Presbyopia. Completed, enrolled 66 participants across 1 site.

Detailed Summary

The purpose of this study was to compare ease of handling and vision acuity of two multifocal contact lenses to correct presbyopia that are currently CE marked and on the UK market.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPresbyopia
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedMar 25, 2024
Enrollment StartFeb 15, 2024
Primary CompletionMay 21, 2024
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 2.3 years ago

Interventions

Lens 1device

Frequent replacement silicone hydrogel contact lens for 14 ± 3 days on a daily disposable wearing modality

Lens 2device

Daily disposable silicone hydrogel contact lens for 14 ± 3 days on a daily disposable wearing modality